StockTitan

@stocktitan.net

2 weeks ago

DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results Fourth quarter 2025 revenues grew sequentially to $5.2 million as compared to $5.0 million in the third quarter of 2025 2025 full-year revenue was $22.4 million, compared to $27.0 million in 2024, due entirely to a scope change and nonrenewal from a single legacy client that came through the Twill, Inc. acquisition— unrelated to demand— partially offset by...

#DRIO DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

www.stocktitan.net/news/DRIO/dario-health-r...

StockTitan

@stocktitan.net

1 month ago

Rising GLP-1 drug costs put Dario’s weight-loss coaching in spotlight Oral GLP-1s are expected to reach 25% of a $95B market by 2030; Dario’s digital tools aim to boost adherence, helping payers improve outcomes and ROI.

#DRIO Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management

www.stocktitan.net/news/DRIO/dario-uniquely...

StockTitan

@stocktitan.net

4 months ago

#DRIO Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio

www.stocktitan.net/news/DRIO/dario-s-data-d...

StockTitan

@stocktitan.net

4 months ago

DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date DarioHealth (NASDAQ: DRIO) announced 34 new employer clients in the past two weeks, bringing 79 clients signed year-to-date, surpassing its 2025 target of 40 new clients by 98%. The new agreements cover tens of thousands of lives and are expected to start contributing to revenue in Q1 2026. Nearly all new clients selected Dario for integrated cardiometabolic care. The company cites clinical outcomes including a 1.4% eHbA1c reduction, 38% blood pressure reduction by one stage, and 10% average BMI reduction. A recent JMIR real-world study with Sanofi and Symphony Health reported 23% lower hospitalization rates and 26% lower all-cause charges for Dario users versus matched usual-care individuals.

#DRIO DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date

www.stocktitan.net/news/DRIO/dario-health-f...

StockTitan

@stocktitan.net

4 months ago

DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year DarioHealth (NASDAQ: DRIO) announced publication of a peer-reviewed retrospective cohort study in Journal of Medical Internet Research showing estimated real-world savings and lower utilization for adults with type 2 diabetes using the Dario digital health platform versus matched usual-care individuals.Key findings: 23.5% lower inpatient hospitalization rates, 26% lower all-cause healthcare resource utilization charges, and an estimated $5,077 gross medical cost savings per patient per year. The 12-month analysis covered 2,445 Dario users vs 7,334 matched controls and reported shorter lengths of stay, lower 30-day readmissions, and a dose-response link between engagement and fewer inpatient/ER events.

#DRIO DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year

www.stocktitan.net/news/DRIO/dario-health-a...

StockTitan

@stocktitan.net

4 months ago

DarioHealth Reports Third Quarter 2025 Financial and Operating Results Third quarter 2025 revenue was $5.0 million, compared to $7.4 million in the third quarter of 2024, and $5.4 million in the second quarter of 2025 Targeting $12.4 million in new business, reflecting both committed annual recurring revenue and late-stage opportunities nearing completion; 2026 pipeline expanded to $69 million Exceeded 2025 goal of 40 new...

#DRIO DarioHealth Reports Third Quarter 2025 Financial and Operating Results

www.stocktitan.net/news/DRIO/dario-health-r...

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

6 months ago

12 Health Care Stocks Moving In Friday's Pre-Market Session - bioAffinity Technologies (NASDAQ:BIAF), Clearside Biomedical (NASDAQ:CLSD) Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.

12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers bioAffinity Technologies (NASDAQ: BIAF ) stock increased by 71.8% to $5.86 during Friday's pre-market session. The compan...

#BIAF #BZI-TFM #CLSD #CRNX #DRIO #GUTS #MDCX #NLSP #ORGO #Penny #Stocks

Origin | Interest | Match

StockTitan

@stocktitan.net

6 months ago

Digital Health Platform DarioHealth Explores Sale After Multiple Acquisition Offers, Raises $17.5M Digital health company DarioHealth (DRIO) forms special committee for strategic review following acquisition interest. Raises $17.5M, bringing cash to $40M. Converts preferred shares to optimize structure.

#DRIO DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest

www.stocktitan.net/news/DRIO/dario-health-a...

StockTitan

@stocktitan.net

6 months ago

$17.5 Million Capital Raise: Digital Health Leader DarioHealth Announces Strategic Stock Placement Digital health company DarioHealth to sell 2.7M shares at $6.45 each in private placement, expecting to raise $17.5M gross proceeds. Closing expected September 23, 2025.

#DRIO DarioHealth Announces $17.5 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules

www.stocktitan.net/news/DRIO/dario-health-a...

StockTitan

@stocktitan.net

7 months ago

$5,000 Per User Annual Savings: DarioHealth's 5-Condition Digital Health Platform Shows 23% Hospital Reduction Digital health leader DarioHealth expands to 5 chronic conditions with $67M pipeline. Platform delivers $5K annual savings per user, 23% fewer hospitalizations across 87M covered lives.

#DRIO DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market

www.stocktitan.net/news/DRIO/dario-health-i...

Thiard News@F4F

@newsen.bsky.social

7 months ago

DarioHealth Implements 20-for-1 Reverse Stock Split to Boost Market Presence DarioHealth Corp. announces a strategic 20-to-1 reverse stock split, aiming to enhance its stock market performance and shareholder value. The move is set for August 28, 2025.

DarioHealth Implements 20-for-1 Reverse Stock Split to Boost Market Presence #USA #New_York #digital_health #DarioHealth #DRIO

StockTitan

@stocktitan.net

7 months ago

DarioHealth Announces 20-to-1 Reverse Stock Split NEW YORK, Aug. 25, 2025/ PRNewswire/-- DarioHealth Corp., a leader in the global digital health market, today announced that a reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share at a ratio of 20- for-1 is expected to be implemented at market open on August 28, 2025. The Company's Common Stock will begin trading on the...

#DRIO DarioHealth Announces 20-to-1 Reverse Stock Split

www.stocktitan.net/news/DRIO/dario-health-a...

Thiard News@F4F

@newsen.bsky.social

7 months ago

DarioHealth Reports Q2 2025 Results with Strong Strategic Momentum Amid Revenue Challenges DarioHealth Corp. revealed its Q2 2025 financial results, indicating lower revenues but significant client onboarding and improved margins, signaling growth potential.

DarioHealth Reports Q2 2025 Results with Strong Strategic Momentum Amid Revenue Challenges #United_States #New_York #digital_health #DarioHealth #DRIO

StockTitan

@stocktitan.net

7 months ago

DarioHealth Reports Second Quarter 2025 Financial and Operating Results DarioHealth (NASDAQ: DRIO) reported Q2 2025 financial results with revenue of $5.4 million, down from $6.3 million in Q2 2024 and $6.8 million in Q1 2025. Despite the revenue decline, the company showed significant operational improvements with a 43% reduction in operating loss and a 36% decrease in operating expenses year-over-year.The company secured 21 new clients year-to-date and reported approximately $5 million in new committed annual recurring revenues (CARR), with a robust pipeline of $53 million in commercial opportunities. Gross margin improved to 55% compared to 44% in Q2 2024, with B2B2C operations maintaining approximately 80% non-GAAP gross margins.Due to implementation delays, Dario has adjusted its cashflow breakeven timeline by 12-15 months, now expected between late 2026 and early 2027.

#DRIO DarioHealth Reports Second Quarter 2025 Financial and Operating Results

www.stocktitan.net/news/DRIO/dario-health-r...

StockTitan

@stocktitan.net

9 months ago

DarioHealth's New Partnership Unlocks $150 Billion Sleep Health Market, Targeting 29M Americans with Unmet Needs Strategic alliance combines AI-powered health solutions with sleep-first approach to transform chronic care management. See how this partnership targets 80% undiagnosed cases.

#DRIO Dario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide

www.stocktitan.net/news/DRIO/dario-and-gree...

StockTitan

@stocktitan.net

9 months ago

Breakthrough Study: Digital Health Platform Maintains GLP-1 Results After Medication Stops New research reveals sustained weight loss post-GLP-1 treatment and AI-powered glucose prediction accuracy. See how digital health platform transforms diabetes care.

#DRIO Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings

www.stocktitan.net/news/DRIO/dario-unveils-...

Small Cap Strategist

@smcapstrategist.bsky.social

10 months ago

Small-cap stocks with improving money flow, Thu Jun 5th - #TBCH #SRDX #RIGL #OCUL #NATR #ENTA #DRIO #CRBP #BWMN #AEHL #WGO #SQNS #ORN #GHM #DBD #CPF #BV - More: crystalequityresearch.com/SmCpStr/ - #smallcap

StockTitan

@stocktitan.net

10 months ago

DarioHealth Reports First Quarter 2025 Financial and Operating Results DarioHealth (DRIO) reported Q1 2025 financial results with revenue of $6.75 million, up 17% year-over-year but down 11% sequentially. The company showed significant margin improvements with gross margin increasing to 57.5% from 42.2% in Q1 2024. Operating expenses decreased by 35% year-over-year to $13.3 million, while GAAP operating loss improved by 47% to $9.4 million. The company signed 14 new clients year-to-date, including health plans and employers, bringing total client count to 97. Dario expanded its platform through strategic partnerships for GLP-1 prescribing, behavioral health, and cardiometabolic support. The company completed an equity raise and debt refinancing, extending its runway to 2028, and remains on track to achieve operational cash flow breakeven by end of 2025.

#DRIO DarioHealth Reports First Quarter 2025 Financial and Operating Results

www.stocktitan.net/news/DRIO/dario-health-r...

StockTitan

@stocktitan.net

11 months ago

DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives DarioHealth (NASDAQ: DRIO) has secured a strategic debt refinancing facility of up to $50 million from Rand Capital and Callodine Group. The company received $32.5 million at closing, with potential access to an additional $17.5 million based on achieving certain revenue thresholds. The five-year credit agreement matures in April 2030 and includes the issuance of warrants to purchase 2,114,140 shares at $0.8278 per share. Notably, the refinancing defers debt amortization from end of 2025 to 2028, providing DarioHealth with enhanced operational flexibility to execute its B2B2C strategy across pharmaceutical companies, self-insured employers, and payer channels.

#DRIO DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives

www.stocktitan.net/news/DRIO/dario-health-c...

StockTitan

@stocktitan.net

11 months ago

Leading US Medical Center Chooses DarioHealth's AI Platform for Multi-Condition Care Top healthcare institution implements Dario's AI-powered solutions for diabetes, mental health, and MSK care, driving 2025 revenue growth. See full partnership details.

#DRIO Top U.S. Healthcare Institution Deploys DarioHealth's Full Suite, Contributing to 2025 Revenue Growth and Market Expansion

www.stocktitan.net/news/DRIO/top-u-s-health...

Small Cap Strategist

@smcapstrategist.bsky.social

1 year ago

Small-cap stocks with strong volume gains, Wed Mar 19th - #GYRE #DRIO #CFB #BDRX #ATER #SPCE #ODV #NRGF #CNF #RAPT #HTZ - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Small Cap Strategist

@smcapstrategist.bsky.social

1 year ago

Most searched small-cap stocks, Mon Mar 10th - #NOEM #OPTX #PFS #OFS #MGIC #LFVN #INDV #HDSN #DRIO #MTUS #KLG #BGS #AIV - More: crystalequityresearch.com/SmCpStr/ - #smallcap

StockTitan

@stocktitan.net

1 year ago

DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results DarioHealth (DRIO) reported strong financial results for Q4 and full-year 2024, with annual revenue increasing 32.9% to $27.0 million. The company's B2B2C channel showed remarkable growth, with recurring revenues rising 300% year-over-year. Q4 2024 revenue reached $7.6 million, up 110% from Q4 2023.Key highlights include completion of a $25.6 million equity financing, resulting in a $34.5 million proforma cash balance. Operating loss decreased by 35% to $11.7 million (GAAP) in Q4 2024. The company added 36 new employer and health plan clients in 2024, bringing total client base to 83, with a projected 50% net client growth in 2025.Following the Twill acquisition, Dario expanded its AI-powered platform to support five chronic conditions. The company expects to achieve operational cash flow breakeven by end of 2025, supported by an anticipated 20% reduction in operating expenses. Gross margins exceeded 80% in the B2B2C business over the past three quarters.

#DRIO DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results

www.stocktitan.net/news/DRIO/dario-health-r...

StockTitan

@stocktitan.net

1 year ago

Can DarioHealth's 15,000-Provider Network Deal Transform Digital Mental Health Access? Strategic partnership combines AI-driven digital coaching with nationwide provider network, creating comprehensive mental health solution for employers and insurance networks.

#DRIO Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula

www.stocktitan.net/news/DRIO/dario-expands-...

StockTitan

@stocktitan.net

1 year ago

DarioHealth Expands Digital Health Empire with Landmark BCBS Deal - AI Platform Set to Transform $1.2T Market DarioHealth partners with Blue Cross Blue Shield, launching AI-driven health coaching for diabetes and cardiometabolic care. Deal marks 9th major health plan partnership.

#DRIO DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base

www.stocktitan.net/news/DRIO/dario-health-a...

StockTitan

@stocktitan.net

1 year ago

DarioHealth Secures $25.6M Funding, Extends Cash Runway Through Q3 2024 Digital health company DarioHealth raises $25.6M in convertible preferred stock placement, boosting cash position to $40.6M. Targets cash flow positive by end of 2025.

#DRIO DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025

www.stocktitan.net/news/DRIO/dario-health-a...

StockTitan

@stocktitan.net

1 year ago

DarioHealth Expands Weight Loss Platform With GLP-1 Prescriptions as Stock Surges 14% DarioHealth strengthens its position in the projected $100B weight loss market by adding GLP-1 prescribing capabilities, combining medication with behavioral health support.

#DRIO DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market

www.stocktitan.net/news/DRIO/dario-health-e...

Market Wire News

@marketwirenews.com

1 year ago

NEWS: ( NASDAQ: #DRIO ) DarioHealth Reports Second Quarter 2024 Financial and Operating Results

#StockMarket #News